Enteric coated risedronate 35mg for the treatment of osteoporosis

Description

In this Product Explainer, Endocrinologist Prof Ego Seeman explains the role of enteric coated risedronate 35mg for the treatment of osteoporosis (5 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Deb Mills

Dr Deb Mills

Travel Medicine Update for General Practice

Dr Katherine Spira

Dr Katherine Spira

Choosing the Right Migraine Preventative

Dr Jay Ramanathan, A/Prof David Sullivan, facilitated by A/Prof Ralph Audehm

Dr Jay Ramanathan, A/Prof David Sullivan, facilitated by A/Prof Ralph Audehm

Expert Panel – Atherosclerosis and Blood Lipid Management

A/Prof Daryl Efron

A/Prof Daryl Efron

Autism – When & Who to Refer

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Ego Seeman

expert

Prof Ego Seeman

Endocrinologist; Dept of Medicine and Endocrinology, Austin Health, University of Melbourne; Editor, Progress in Osteoporosis

Date published: 7 November 2023